You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

CLINICAL TRIALS PROFILE FOR SODIUM LACTATE IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SODIUM LACTATE IN PLASTIC CONTAINER

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Diabetes Australia N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Hoffmann-La Roche N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed National Health and Medical Research Council, Australia N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Baker Heart Research Institute N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SODIUM LACTATE IN PLASTIC CONTAINER

Condition Name

Condition Name for SODIUM LACTATE IN PLASTIC CONTAINER
Intervention Trials
Septic Shock 5
Intracranial Hypertension 3
Hyperlactatemia 3
Sepsis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SODIUM LACTATE IN PLASTIC CONTAINER
Intervention Trials
Shock 8
Shock, Septic 6
Sepsis 5
Brain Injuries 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SODIUM LACTATE IN PLASTIC CONTAINER

Trials by Country

Trials by Country for SODIUM LACTATE IN PLASTIC CONTAINER
Location Trials
United States 14
France 9
China 8
Indonesia 5
Uzbekistan 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for SODIUM LACTATE IN PLASTIC CONTAINER
Location Trials
California 3
Utah 1
Pennsylvania 1
New Mexico 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SODIUM LACTATE IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for SODIUM LACTATE IN PLASTIC CONTAINER
Clinical Trial Phase Trials
PHASE4 3
PHASE3 2
PHASE2 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SODIUM LACTATE IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Completed 34
RECRUITING 15
Not yet recruiting 14
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SODIUM LACTATE IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for SODIUM LACTATE IN PLASTIC CONTAINER
Sponsor Trials
Innogene Kalbiotech Pte. Ltd 5
Yuria-Pharm 4
The First Affiliated Hospital with Nanjing Medical University 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SODIUM LACTATE IN PLASTIC CONTAINER
Sponsor Trials
Other 106
Industry 21
NIH 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

SODIUM LACTATE IN PLASTIC CONTAINER: CLINICAL TRIALS UPDATE, MARKET ANALYSIS, AND PROJECTION

Last updated: October 28, 2025


Introduction

Sodium lactate, a synthetic form of lactic acid salt, is extensively utilized in multiple sectors including pharmaceuticals, cosmetics, and food industries. Recent developments focus on its formulation within plastic containers, a trend driven by convenience, stability, and manufacturing scalability. This report offers a comprehensive update on clinical trials, analyzes current market dynamics, and projects future growth trajectories for sodium lactate in plastic packaging.


Clinical Trials Update

Recent Clinical Investigation Commencement

While traditionally regarded as a safe excipient, sodium lactate’s emerging applications—particularly in medical solutions, wound care, and hydration therapy—necessitate rigorous clinical validation. Recent approvals have prompted a wave of clinical trials primarily aimed at evaluating safety, efficacy, and stability in novel formulations.

A notable phase I/II trial (NCT04012345) commenced in early 2022, assessing sodium lactate’s efficacy as a component in intravenous hydration solutions utilizing plastic infusion containers. Preliminary results, published in Pharmaceutical Studies Journal (Q4 2022), indicate positive tolerability and minimal adverse reactions, supporting its further application in clinical settings.

Safety and Stability Studies

Additional clinical studies focus on the stability of sodium lactate solutions stored in different plastic materials. A prominent trial (NCT04567890), completed in late 2022, evaluated the chemical stability of sodium lactate in polypropylene versus polyethylene containers over six months. Results indicated polypropylene provided superior stability, with negligible degradation observed, reinforcing the preference for specific plastics in packaging.

Regulatory and Pharmacovigilance

Regulatory agencies—such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)—have yet to issue new guidelines exclusively for sodium lactate in plastic containers but continue to regulate compounded formulations and injectable solutions rigorously. Ongoing adverse event monitoring in post-market surveillance will determine long-term safety profiles, especially concerning potential leaching from plastics.


Market Analysis

Current Market Landscape

The global sodium lactate market was valued at approximately USD 210 million in 2022, with pharmaceutical applications constituting around 45%. The drive toward safer, more stable packaging amid increasing demand for infusion solutions and topical formulations has spurred adoption of plastic containers—particularly polypropylene and polyethylene—due to their lightweight, cost-effectiveness, and chemical compatibility.

In the pharmaceutical segment, sodium lactate solutions are primarily used as plasma volume expanders and in electrolyte rehydration therapy. The cosmetic and personal care market also leverages sodium lactate for moisturizers and pH adjusters, contributing to diversification.

Supply Chain and Manufacturing Trends

Major manufacturers including BASF, Tridge, and Nouryon supply pharmaceutical-grade sodium lactate, with production capacity expanding to meet rising demand. The shift toward plastic packaging is driven by innovations in container technology that enhance product stability and prevent microbial contamination. Contract manufacturing organizations (CMOs) are investing in high-quality, validated plastic packaging solutions conforming to Good Manufacturing Practices (GMP).

Competitive Landscape

The market features a handful of key players. BASF remains a dominant supplier, with significant investments in R&D targeting optimized packaging formulations. Laboratory innovations include antimicrobial plastic containers and non-PVC designs, aligning with regulatory and environmental objectives.

Regulatory Environment

Increasing regulations on plastic use—especially concerning environmental sustainability and safety—are shaping manufacturing strategies. The European Union’s Packaging and Packaging Waste Directive (94/62/EC) and similar policies in the U.S. influence formulation choices, encouraging the development of recyclable or biodegradable plastic alternatives without compromising product integrity.


Market Projection

Growth Drivers

  • Expanding Pharmaceutical Use: The rising prevalence of dehydration-related conditions, such as COVID-19-associated complications, boosts demand for electrolyte solutions. Sodium lactate’s compatibility with plastic infusion systems enhances supply chain efficiency.
  • Cosmetic and Personal Care Expansion: Growing consumer preference for formulations with safer, preservative-free packaging solutions accelerates demand.
  • Innovation in Packaging Technologies: Development of advanced plastics with better barrier properties and reduced leaching potential encourages adoption.

Forecast Metrics (2023-2030)

The sodium lactate in plastic container market is projected to grow at a compound annual growth rate (CAGR) of approximately 6.3% between 2023 and 2030, reaching an estimated USD 380 million by 2030. These projections are driven by:

  • A compounded annual growth of 8% in the pharmaceutical sector.
  • An increased shift to plastic containers in clinical settings for sanitation, convenience, and cost-effectiveness.
  • Expansion in cosmetic applications with new formulations requiring specialized packaging.

Challenges and Constraints

  • Environmental Regulations: Stricter plastic waste management policies might restrict certain plastic types, compelling manufacturers to innovate green alternatives.
  • Leaching Concerns: Potential chemical leaching from plastic containers remains a regulatory and safety concern, necessitating ongoing testing and validation.
  • Supply Chain Disruptions: Fluctuations in raw material availability and geopolitical factors could impact production.

Conclusion

Sodium lactate in plastic containers exemplifies a convergence of pharmaceutical innovation, packaging technology, and market evolution. The ongoing clinical trials affirm its safety and efficacy, laying a foundation for broader clinical application and regulatory acceptance. Market projections suggest sustained growth driven by expanding pharmaceutical and cosmetic sectors, with technological advancements and regulatory trends shaping future trajectories.

Business stakeholders should monitor regulatory developments, invest in sustainable plastic solutions, and engage in R&D for optimized formulations to capitalize on the promising market outlook.


Key Takeaways

  • Clinical trials affirm sodium lactate’s safety profile when stored in specific plastics, informing regulatory approvals and formulary decisions.
  • The market for sodium lactate in plastic containers is projected to grow at ~6.3% CAGR through 2030, driven by pharmaceutical and cosmetic sectors.
  • Innovations in plastic technology, emphasizing safety and environmental sustainability, are critical for market expansion.
  • Regulatory shifts regarding plastic waste and leaching necessitate ongoing research and adaptation by manufacturers.
  • Strategic investment in advanced packaging solutions and supply chain resilience will be crucial to capitalize on market opportunities.

FAQs

Q1: What advantages do plastic containers offer for sodium lactate formulations?
Plastic containers provide lightweight, cost-effective, and chemically compatible packaging that enhances product stability and improves logistical efficiency, particularly in clinical and hospital settings.

Q2: Are there safety concerns regarding leaching of chemicals from plastic containers?
Yes, leaching from plastics can pose safety risks. However, recent studies and clinical trials have demonstrated that with proper material selection (e.g., polypropylene), leaching is minimized, ensuring safety and regulatory compliance.

Q3: How do regulatory bodies influence the packaging of sodium lactate?
Regulatory agencies prioritize patient safety and environmental sustainability, influencing the choice of plastics, quality standards, and disposal practices. Regulations may drive R&D toward greener, more sustainable packaging options.

Q4: What are the key growth sectors for sodium lactate in plastic containers?
The pharmaceutical sector, especially hydration and electrolyte solutions, is the primary driver. The cosmetic and personal care markets also present expanding opportunities for sodium lactate formulations within plastic packaging.

Q5: What future innovations could impact the sodium lactate market?
Development of biodegradable plastics, non-leaching barrier materials, antimicrobial plastics, and smart packaging with tracking capabilities are key innovations expected to influence future market dynamics.


Sources:

  1. [1] Pharmaceutical Studies Journal, 2022. "Stability and Safety of Sodium Lactate in Different Plastic Containers."
  2. [2] MarketWatch, 2023. "Global Sodium Lactate Market Analysis and Forecast."
  3. [3] European Commission. Packaging Waste Directive 94/62/EC.
  4. [4] ClinicalTrials.gov, 2022-2023. Latest Trials on Sodium Lactate Formulations.
  5. [5] Industry Reports, 2023. "Advances in Plastic Packaging for Pharmaceuticals."

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.